TNGX
Tango Therapeutics Inc
25.50$
+14.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.28 | 0.09 | 0.60 | 0.28 | 0.39 | 0.39 | 0.54 | |
| 0.37 | 0.02 | 0.03 | 0.05 | 1.22 | 0.02 | 0.02 | |
| -0.09 | 0.07 | 0.60 | 0.28 | 0.39 | 0.39 | 0.52 | |
| 0.37 | 0.57 | 1.25 | 1.21 | 1.22 | 1.32 | 1.14 | |
| 0.09 | 0.11 | 0.28 | 0.34 | 0.38 | 0.40 | 0.36 | |
| 0.09 | 0.67 | 1.53 | 1.55 | 1.59 | 1.72 | 1.48 | |
| -0.17 | -0.60 | -0.94 | -1.26 | -1.21 | -1.33 | -0.96 | |
| 0.00 | 0.00 | 0.02 | 0.03 | – | – | – | |
| -0.16 | -0.59 | -0.93 | -1.23 | -1.07 | -1.19 | -0.87 | |
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.16 | -0.59 | -0.94 | -1.23 | -1.08 | -1.19 | -0.87 | |
| -0.17 | -0.58 | -0.92 | -1.25 | -1.05 | -1.17 | -0.85 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.